Stock listing
Qyuns Therapeutics Co., Ltd. Class H
Selected listing: QYUNF · OTC · USD · US
Qyuns Therapeutics Co., Ltd. Class H (OTC:QYUNF), Health Technology. Latest release Oct 2, 2026: VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS…
- Ticker
- OTC:QYUNF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Latest news from Qyuns Therapeutics Co., Ltd. Class H
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS OF OTURKIBART (QX005N) FOR TREATMENT OF PRURIGO NODULARIS PRESENTED AS A LATE-BREAKING ORAL PRESENTATION AT EADV 2026
October 1, 2026
A Decade of Persistent Steps, Aspiring for a Thousand Miles: Qyuns' Grand 10th Anniversary Celebration Held Successfully
June 16, 2025
Research Qyuns Therapeutics Co., Ltd. Class H
Qyuns Therapeutics Co., Ltd. Class H company profile
View the public company page for Qyuns Therapeutics Co., Ltd. Class H on 6ix.
Qyuns Therapeutics Co., Ltd. Class H news
Read company news and market updates connected to Qyuns Therapeutics Co., Ltd. Class H.
Qyuns Therapeutics Co., Ltd. Class H investor events
Find investor webinars, events, and replay context for Qyuns Therapeutics Co., Ltd. Class H.